These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 33202195)

  • 21. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy.
    Hong R; Zhao H; Wang Y; Chen Y; Cai H; Hu Y; Wei G; Huang H
    Bone Marrow Transplant; 2021 Mar; 56(3):570-580. PubMed ID: 32943758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections.
    Remy KE; Mazer M; Striker DA; Ellebedy AH; Walton AH; Unsinger J; Blood TM; Mudd PA; Yi DJ; Mannion DA; Osborne DF; Martin RS; Anand NJ; Bosanquet JP; Blood J; Drewry AM; Caldwell CC; Turnbull IR; Brakenridge SC; Moldwawer LL; Hotchkiss RS
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32687484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application value of artificial liver support system in the treatment of cytokine storm in patients with COVID-19.
    Xia Q; Xu K; Yu L; Zhang H; Li L
    Int Immunopharmacol; 2021 Jan; 90():107120. PubMed ID: 33162345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model.
    Gu T; Zhao S; Jin G; Song M; Zhi Y; Zhao R; Ma F; Zheng Y; Wang K; Liu H; Xin M; Han W; Li X; Dong CD; Liu K; Dong Z
    Front Immunol; 2020; 11():621441. PubMed ID: 33584719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center.
    Li Y; Shang Y; Yang Y; Wang M; Yu D; Su D; Liu L; Wang Q; Zhang X; Ren J; Chen H
    Respiration; 2020; 99(9):739-747. PubMed ID: 33207356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID-19 Patients: A Retrospective Cohort Study.
    Shi C; Wang C; Wang H; Yang C; Cai F; Zeng F; Cheng F; Liu Y; Zhou T; Deng B; Vlodavsky I; Li JP; Zhang Y
    Clin Transl Sci; 2020 Nov; 13(6):1087-1095. PubMed ID: 32881340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laboratory abnormalities and risk factors associated with in-hospital death in patients with severe COVID-19.
    Chen X; Yan L; Fei Y; Zhang C
    J Clin Lab Anal; 2020 Oct; 34(10):e23467. PubMed ID: 32656888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
    Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
    BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of clinical value of Xuebijing combined with human immunoglobulin in severe and critically ill patients with coronavirus disease 2019].
    Chen L; Zhang A; Li Q; Cui Y; Yuan G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Apr; 33(4):399-404. PubMed ID: 34053480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19.
    Sims JT; Krishnan V; Chang CY; Engle SM; Casalini G; Rodgers GH; Bivi N; Nickoloff BJ; Konrad RJ; de Bono S; Higgs RE; Benschop RJ; Ottaviani S; Cardoso A; Nirula A; Corbellino M; Stebbing J
    J Allergy Clin Immunol; 2021 Jan; 147(1):107-111. PubMed ID: 32920092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of clinical deterioration in non-severe patients with COVID-19: a retrospective cohort study.
    Yitao Z; Mu C; Ling Z; Shiyao C; Jiaojie X; Zhichong C; Huajing P; Maode O; Kanglin C; Mao OY; Xiaoneng M; Weijie Z
    Curr Med Res Opin; 2021 Mar; 37(3):385-391. PubMed ID: 33459077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i).
    Pinheiro MM; Fabbri A; Infante M
    Immunotherapy; 2021 Jun; 13(9):753-765. PubMed ID: 33906375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory Response and Phenotyping in Severe Acute Respiratory Infection From the Middle East Respiratory Syndrome Coronavirus and Other Etiologies.
    Arabi YM; Jawdat D; Hajeer AH; Sadat M; Jose J; Vishwakarma RK; Almashaqbeh W; Al-Dawood A
    Crit Care Med; 2021 Feb; 49(2):228-239. PubMed ID: 33181590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The features comparison between patients in the ICU and general wards and between patients with different outcomes: a 2020 COVID-19 study.
    Chen Y; Geng Y; Xu X; Chen X; Gao J; Li J; Zhang X
    Ann Palliat Med; 2021 Jan; 10(1):672-680. PubMed ID: 33545796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.
    Wang Z; Wang Z
    BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex.
    Petrey AC; Qeadan F; Middleton EA; Pinchuk IV; Campbell RA; Beswick EJ
    J Leukoc Biol; 2021 Jan; 109(1):55-66. PubMed ID: 32930456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infusion of HLA-matched and static magnetic field-exposed allogenic lymphocytes treating lymphocytopenia and cytokine storm syndrome: A treatment proposal for COVID-19 patients.
    Vergallo C
    Electromagn Biol Med; 2021 Jan; 40(1):11-25. PubMed ID: 33073612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.